BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3086016)

  • 1. Immunologic complexity of lymphoblastic lymphoma.
    Grogan T; Spier C; Wirt DP; Hicks MJ; Paquin M; Hutter J; Miller T; Rangel C; Richter L; Jones S
    Diagn Immunol; 1986; 4(2):81-8. PubMed ID: 3086016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of immunological phenotypes of lymphoblastic lymphoma.
    Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
    Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypic analysis of human T-cell lymphoma with reference to cell differentiation and morphological classification].
    Feller AC
    Veroff Pathol; 1989; 131():1-175. PubMed ID: 2694674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level.
    van Dongen JJ; Quertermous T; Bartram CR; Gold DP; Wolvers-Tettero IL; Comans-Bitter WM; Hooijkaas H; Adriaansen HJ; de Klein A; Raghavachar A
    J Immunol; 1987 Feb; 138(4):1260-9. PubMed ID: 3100631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.
    Tedder TF; Crain MJ; Kubagawa H; Clement LT; Cooper MD
    J Immunol; 1985 Sep; 135(3):1786-91. PubMed ID: 3160779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
    Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
    Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S; Juco J; Mann KP; Holden JT
    Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocyte-associated antigens on terminal deoxynucleotidyl transferase-positive cells and pre-B cells in bone marrow of the rat.
    Opstelten D; Deenen GJ; Rozing J; Hunt SV
    J Immunol; 1986 Jul; 137(1):76-84. PubMed ID: 3086459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
    Miles RR; Cairo MS; Satwani P; Zwick DL; Lones MA; Sposto R; Abromovitch M; Tripp S; Angiolillo AL; Roman E; Davenport V; Perkins SL
    Br J Haematol; 2007 Aug; 138(4):506-12. PubMed ID: 17659054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
    Soslow RA; Baergen RN; Warnke RA
    Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic and enzymatic markers of acute infantile lymphoblastic leukemias].
    González M; Tamagnini G; San Miguel JF; Lopes DT; Mateos G; Caballero MD; Ribeiro L; López Borrasca A
    An Esp Pediatr; 1984 Sep; 21(3):222-8. PubMed ID: 6594963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.